Peptide aesthetic therapy most reasonably describes topical skin-care products containing short amino-acid chains. Products may use signal peptides, carrier peptides such as copper complexes, or formulas marketed to influence the appearance of fine lines and skin texture. Effects, penetration, stability, and evidence depend on the exact ingredient and formulation.
Cosmetics are not injectable drugs
A topical peptide serum, a compounded injection, and a product applied into fresh microneedling channels are not the same exposure. Most topical peptide products are cosmetics and are not FDA-approved to treat disease or permanently change skin structure. Injectable or compounded “aesthetic peptides” may be unapproved drugs with uncertain identity, sterility, dosing, and long-term safety.
Evidence and expectations
Small studies and laboratory data suggest selected formulations may modestly improve hydration or the appearance of fine lines over weeks to months. Many studies are short, formulation-specific, or manufacturer-associated. Results should not be generalized from one peptide to every product. Daily broad-spectrum sunscreen and evidence-based topical treatments such as retinoids generally have a stronger clinical foundation for photoaging.
Microneedling and post-procedure use
FDA’s aesthetic microneedling device classification does not include devices intended to deliver cosmetics, drugs, or biologics through the skin. Applying a serum to punctured or ablated skin can increase exposure and contamination or inflammatory risk. Use only products and timing specifically supported by the device instructions and treating clinician; “sterile” marketing alone does not establish authorization for intradermal delivery.
Buying and using products
Review the full ingredient list, packaging, expiration, intended route, and manufacturer. Patch test when appropriate and introduce one active at a time. Stop for persistent burning, swelling, blistering, hives, or worsening dermatitis. Do not inject products labeled for topical use.